Oral Semaglutide in Patients With Alzheimer's Disease

NCT07200622 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Semaglutide (Rybelsus®)
DRUG: Placebo

Sponsor

Imperial College London